Sclerostin inhibition increases bone mass and bone defect regeneration in rats with type 2 diabetes mellitus
C. Hamann⁎, Y. Höhna, M. Rauner, J. Mettelsiefen, C. Göttsch, R. Bernhardt, K.-P. Günther, M.S. Ominsky, L.C. HofbauerVolume:
50
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2012.02.202
File:
PDF, 95 KB
english, 2012